Interleukin-6 as a Risk and Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis. J. Can. Res. Updates [Internet]. 2024 Nov. 14 [cited 2026 May 25];13:42-51. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/783